Brodalumab Is Effective for Psoriasis Patients with Difficult-To-Treat Body Regions: Results from an Observational Clinical Study
Outcomes assessed in this study, including assessments of scalp and nail symptoms, improved following initiation of brodalumab therapy. This study of psoriasis patients in a real-world setting supports the long-term clinical effectiveness of brodalumab on difficult-to-treat body regions.
Authors
- Konstantin Hallmann (ORCID: https://orcid.org/0000-0003-3241-2918)
- Andreas Pinter (ORCID: https://orcid.org/0000-0002-1330-1502)
- Ann Christina Foldenauer (ORCID: https://orcid.org/0000-0003-2049-3204)
- Isabel Haferland (ORCID: https://orcid.org/0000-0003-2256-1637)
- Michaela Köhm (ORCID: https://orcid.org/0000-0002-3579-5574)
- Christine Möser (ORCID: https://orcid.org/0000-0003-0229-7808)
- Anke König (ORCID: https://orcid.org/0000-0001-9969-2315)
- Christina Kunz (ORCID: https://orcid.org/0009-0001-9483-2355)
- Stephanie Dauth (ORCID: https://orcid.org/0000-0002-2752-3739)
Institutions
- Goethe University Frankfurt (DE)
- Fraunhofer Institute for Translational Medicine and Pharmacology (DE)
- University Hospital Frankfurt (DE)
Publication Details
- Journal
- Dermatology
- Published
- 2024-11-06
- DOI
- https://doi.org/10.1159/000542348
- Citations
- 1
- Primary Topic
- Psoriasis: Treatment and Pathogenesis
- Type
- article
- Field-Weighted Citation Impact
- 0.24